Please ensure Javascript is enabled for purposes of website accessibility

Why American Well Was a Big Winner on Monday

By Eric Volkman – Oct 12, 2020 at 7:38PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Several analysts are giving the stock an enthusiastic thumbs-up.

What happened

A recent arrival to the stock exchange, telehealth services specialist American Well (AMWL -8.09%), has been a favorite of investors. It seems as if the stock is becoming a favorite of analysts too. On Monday, prognosticators from several prominent companies initiated coverage on the stock, several with emphatic buy recommendations. Not surprisingly, American Well (a.k.a. Amwell) shot higher in trading, closing the day up by 6.3%.

So what

New members of the Amwell Fan Club include Cowen's Charles Rhyee. He launched his coverage of the stock with a $41-per-share price target -- 18% higher that its latest closing -- and an outperform rating.

Woman using telemedicine services.

Image source: Getty Images.

Bloomberg quoted Rhyee as saying that "Telehealth is currently one of the biggest themes in healthcare, and ... AMWL should benefit from its focus on providers, who we see being a key driver in the next leg of growth in telehealth."

Another researcher bullish Amwell is Piper Sandler, which on Monday tagged them with an overweight recommendation at $44 per share.

Now what

However, since telehealth is one of the hottest segments in the healthcare sector at the moment, Amwell stock is on fire. Its price has risen by over 51% since it hit the stock exchange less than a month ago.

So, some of the new initiations have been significantly less bullish. One is Morgan Stanley analyst Ricky Goldwasser, who believes it is fairly priced at $35, giving it an equal weight recommendation.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Amwell Stock Quote
$3.41 (-8.09%) $0.30
Morgan Stanley Stock Quote
Morgan Stanley
$89.89 (-1.12%) $-1.02
Piper Sandler Companies Stock Quote
Piper Sandler Companies
$141.66 (-4.16%) $-6.15
Cowen Group Stock Quote
Cowen Group
$38.73 (%)

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.